Cardiovascular Therapeutics / 2020 / Article / Tab 2

Clinical Study

Predictive Value of Electromechanical Activation Time for In-Hospital Major Cardiac Adverse Events in Heart Failure Patients

Table 2

Comparison of treatments during hospitalization between MACE and nonMACE groups.

MACE NonMACE value

receptor antagonist10 (45.5%)83 (67.5%)0.047
ACEI/ARB7 (31.8%)65 (52.8%)0.069
Diuretics18 (81.8%)89 (72.4%)0.353

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.